Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Baboon envelope pseudotyped lentiviral vectors: a highly efficient new tool to genetically manipulate T-cell acute lymphoblastic leukaemia-initiating cells.

Leukemia·2016
Same author

Baboon envelope pseudotyped lentiviral vectors efficiently transduce human B cells and allow active factor IX B cell secretion in vivo in NOD/SCIDγc<sup>-/-</sup> mice.

Journal of thrombosis and haemostasis : JTH·2016
Same author

T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates.

Gene therapy·2016
Same author

Measles virus glycoprotein-pseudotyped lentiviral vectors are highly superior to vesicular stomatitis virus G pseudotypes for genetic modification of monocyte-derived dendritic cells.

Journal of virology·2012
Same author

Efficient transduction of healthy and malignant plasma cells by lentiviral vectors pseudotyped with measles virus glycoproteins.

Leukemia·2012
Same author

Transgenic rabbit production with simian immunodeficiency virus-derived lentiviral vector.

Transgenic research·2010
Same journal

[From rhizomania to viral RNAs structure functions].

Virologie (Montrouge, France)·2026
Same journal

[Characteristics of viral gastroenteritis in solid organ transplant patients].

Virologie (Montrouge, France)·2026
Same journal

[ResaFlu/FluResearchNet International symposium,Toulouse, November 26-27, 2025].

Virologie (Montrouge, France)·2026
Same journal

[ViRAE 2025: a landmark inaugural edition for virology at INRAE].

Virologie (Montrouge, France)·2026
Same journal

[13<sup>rd</sup> Cytokines annual meeting, Novembre 2-5 2025, Seattle, USA].

Virologie (Montrouge, France)·2026
Same journal

[Annual report of the French Society for Virology].

Virologie (Montrouge, France)·2026
See all related articles

Related Experiment Video

Updated: Oct 16, 2025

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.4K

[Hepatitis C virus cell entry].

F-L Cosset1

  • 1Inserm U758, Lyon ; École normale supérieure de Lyon ; IFR128 BioSciences Lyon-Gerland, Lyon.

Virologie (Montrouge, France)
|October 23, 2021
PubMed
Summary
This summary is machine-generated.

Hepatitis C virus (HCV) cell entry mechanisms are becoming clearer thanks to emerging in vitro models. This review details the roles of HCV envelope glycoproteins E1 and E2 in viral attachment, receptor interactions, and fusion.

Keywords:
cell entryenvelopefusionglycoproteinreceptor

More Related Videos

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

11.8K
Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

7.6K

Related Experiment Videos

Last Updated: Oct 16, 2025

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.4K
Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

11.8K
Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

7.6K

Area of Science:

  • Virology
  • Molecular Biology

Context:

  • Hepatitis C virus (HCV), a significant human pathogen, is an enveloped, positive-stranded RNA virus.
  • Understanding HCV cell entry is crucial due to its global health impact.

Purpose:

  • To review the contribution of various HCV model systems to understanding viral cell entry.
  • To summarize knowledge on the structure and function of HCV envelope glycoproteins E1 and E2 in cell entry.

Summary:

  • HCV cell entry involves initial attachment via low-affinity molecules and subsequent high-affinity receptor interactions.
  • The process includes endocytosis, trafficking, and fusion mediated by viral glycoproteins.
  • Emerging in vitro systems are now aiding the study of HCV replication and particle formation.

Impact:

  • Advances knowledge of Hepatitis C virus pathogenesis.
  • Provides insights into viral entry mechanisms for potential therapeutic targets.